KR20200084877A - 근육 이영양증을 치료하기 위한 이다살론익센트 투약 레지멘 - Google Patents

근육 이영양증을 치료하기 위한 이다살론익센트 투약 레지멘 Download PDF

Info

Publication number
KR20200084877A
KR20200084877A KR1020207015893A KR20207015893A KR20200084877A KR 20200084877 A KR20200084877 A KR 20200084877A KR 1020207015893 A KR1020207015893 A KR 1020207015893A KR 20207015893 A KR20207015893 A KR 20207015893A KR 20200084877 A KR20200084877 A KR 20200084877A
Authority
KR
South Korea
Prior art keywords
dose
hours
administered
compound
certain embodiments
Prior art date
Application number
KR1020207015893A
Other languages
English (en)
Korean (ko)
Inventor
앤드류 제이. 니콜스
미쉘 펄만
Original Assignee
카타베이시스 파마슈티칼즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 카타베이시스 파마슈티칼즈, 인코포레이티드 filed Critical 카타베이시스 파마슈티칼즈, 인코포레이티드
Publication of KR20200084877A publication Critical patent/KR20200084877A/ko

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
KR1020207015893A 2017-11-06 2018-11-05 근육 이영양증을 치료하기 위한 이다살론익센트 투약 레지멘 KR20200084877A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762581981P 2017-11-06 2017-11-06
US62/581,981 2017-11-06
PCT/US2018/059283 WO2019090271A1 (en) 2017-11-06 2018-11-05 Edasalonexent dosing regimen for treating muscular dystrophy

Publications (1)

Publication Number Publication Date
KR20200084877A true KR20200084877A (ko) 2020-07-13

Family

ID=66332350

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207015893A KR20200084877A (ko) 2017-11-06 2018-11-05 근육 이영양증을 치료하기 위한 이다살론익센트 투약 레지멘

Country Status (16)

Country Link
US (1) US20210023029A1 (pt)
EP (1) EP3706730A4 (pt)
JP (1) JP2021502328A (pt)
KR (1) KR20200084877A (pt)
CN (1) CN111315372A (pt)
AU (1) AU2018359969A1 (pt)
BR (1) BR112020009020A2 (pt)
CA (1) CA3078727A1 (pt)
CL (1) CL2020001180A1 (pt)
CO (1) CO2020006395A2 (pt)
IL (1) IL274375A (pt)
MX (1) MX2020004659A (pt)
PH (1) PH12020550526A1 (pt)
RU (1) RU2020118258A (pt)
SG (1) SG11202004115WA (pt)
WO (1) WO2019090271A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020191087A1 (en) * 2019-03-18 2020-09-24 Ptc Therapeutics, Inc. Therapeutic combinations for use in treating a muscular dystrophy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0915536A2 (pt) * 2008-07-08 2019-01-15 Catabasis Pharmaceuticals Inc salicilatos acetilados de ácidos graxos e seus usos
PT2519230T (pt) * 2009-12-31 2019-01-18 Marius Pharmaceuticals Llc Modulação de solubilidade, estabilidade, absorção, metabolismo e perfil farmacocinético de fármacos lipofílicos por esteróis
MX337605B (es) * 2010-01-08 2016-03-10 Catabasis Pharmaceuticals Inc Derivados de fumarato de acido graso y sus usos.

Also Published As

Publication number Publication date
PH12020550526A1 (en) 2021-05-10
EP3706730A1 (en) 2020-09-16
JP2021502328A (ja) 2021-01-28
CL2020001180A1 (es) 2020-09-25
CN111315372A (zh) 2020-06-19
EP3706730A4 (en) 2021-08-11
BR112020009020A2 (pt) 2020-10-27
US20210023029A1 (en) 2021-01-28
IL274375A (en) 2020-06-30
AU2018359969A1 (en) 2020-05-14
WO2019090271A1 (en) 2019-05-09
SG11202004115WA (en) 2020-06-29
CO2020006395A2 (es) 2020-06-09
CA3078727A1 (en) 2019-05-09
MX2020004659A (es) 2020-10-14
RU2020118258A (ru) 2021-12-08

Similar Documents

Publication Publication Date Title
KR101068603B1 (ko) 지방 조직, 피부 조직, 피부 질환 및 근육 조직의 치료를 위한 제제
JP7033642B2 (ja) 選択的s1p1レセプターアゴニストを含む薬学的合剤
JP7053478B2 (ja) Fxrアゴニストを使用するための方法
CA3121920A1 (en) Crf1 receptor antagonist, pharmaceutical formulations and solid forms thereof for the treatment of congenital adrenal hyperplasia
AU2016304737B2 (en) Methods of sedation and parenteral formulation for use during critical care treatment
US10583105B2 (en) Compositions and methods for neuroprotection and treatment of neurodegeneration
JP2022537366A (ja) Lpc-dha、lpc-epaなどの非経口リゾホスファチジルコリン製剤及びそれらの治療における使用
JP7175272B2 (ja) 筋萎縮の治療におけるトリプトファン代謝物質の使用
JP2022543837A (ja) てんかん重積状態の治療に使用するためのガナキソロン
KR20200084877A (ko) 근육 이영양증을 치료하기 위한 이다살론익센트 투약 레지멘
WO2017027249A1 (en) Methods of sedation and parenteral formulation for use during critical care treatment
TWI626043B (zh) 苯甲酸鋰用於治療中樞神經系統疾病的用途
WO2019088881A1 (ru) Комбинации эдаравона для лечения ишемических повреждений мозга
WO2021004422A1 (zh) 小分子PI4KIIIα抑制剂组合物、其制备方法及用途
US20160228353A1 (en) Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation
AU2018298431A1 (en) Use of edaravone in oral treatment of oxidative-stress mediated neurodegenerative disorders
CN112654626A (zh) 化合物及其用途
CA3204701A1 (en) Topical pharmaceutical compositions and methods
EP3607948A1 (en) Tissue transglutaminase modulators for medicinal use
US20230333087A1 (en) Methods for monitoring patient response to treatment of retinal oxidative diseases
KR20180030025A (ko) 질환의 치료를 위한 헤테로아릴 카보나이트릴
US20230277491A1 (en) Pharmaceutical combination comprising glycolic acid and l-alanine
US20210121425A1 (en) Electrophilic nitroalkene benzoic acid derivates as therapeutic drugs in amyotrophic lateral sclerosis (als) and other neurodegenerative conditions
KR20240109697A (ko) 나프토퀴논계 화합물을 포함하는 조성물 및 연질 캡슐 제형
EA043008B1 (ru) Комбинации эдаравона для лечения ишемических повреждений мозга